Renaissance Technologies’s BeOne Medicines Ltd ONC Stock Holding History

Renaissance Technologies’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.1M	Buy	101,980 +36,524	+56%	+$10.8M	0.04%	546
2026 Q1	$19.4M	Buy	+65,456	New	+$21.2M	0.03%	659
2023 Q3	–	Sell	-9,300	Closed	-$1.66M	–	4196
2023 Q2	$1.66M	Buy	+9,300	New	+$2.14M	﹤0.01%	2121
2022 Q4	–	Sell	-2,300	Closed	-$310K	–	4480
2022 Q3	$310K	Buy	+2,300	New	+$395K	﹤0.01%	3195
2020 Q1	–	Sell	-30,619	Closed	-$5.08M	–	3879
2019 Q4	$5.08M	Buy	+30,619	New	+$5.09M	﹤0.01%	1846
2018 Q4	–	Sell	-142,500	Closed	-$24.5M	–	3669
2018 Q3	$24.5M	Sell	142,500 -74,616	-34%	-$12.5M	0.03%	810
2018 Q2	$33.4M	Buy	+217,116	New	+$38.7M	0.04%	625
2017 Q2	–	Sell	-6,500	Closed	-$238K	–	3397
2017 Q1	$238K	Buy	+6,500	New	+$237K	﹤0.01%	2966
2016 Q4	–	Sell	-30,900	Closed	-$952K	–	3497
2016 Q3	$952K	Buy	+30,900	New	+$897K	﹤0.01%	2589

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies's ONC Position: Q2 2026 in Review

Renaissance Technologies increased its BeOne Medicines Ltd (ONC) stake by 56% in Q2 2026, buying an estimated $10.8M and bringing the position to 101,980 shares worth $29.1M. The position accounts for 0.04% of the portfolio, ranked #546.

Renaissance Technologies first reported a position in ONC in Q3 2016 and has held it in 9 quarters since. The position peaked at $33.4M in Q2 2018. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Renaissance Technologies held 101,980 shares of BeOne Medicines Ltd worth $29.1M as of Q2 2026.
Renaissance Technologies bought 36,524 BeOne Medicines Ltd shares in Q2 2026, an estimated $10.8M.
BeOne Medicines Ltd made up 0.04% of Renaissance Technologies's portfolio in Q2 2026, its #546 holding.
Renaissance Technologies first reported a position in BeOne Medicines Ltd in Q3 2016 and has held it in 9 quarters since.
Renaissance Technologies's BeOne Medicines Ltd position peaked at $33.4M in Q2 2018.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.